SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

723

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

November 10, 2024

Study Completion Date

December 31, 2028

Conditions
Peripheral Artery Disease
Interventions
DEVICE

SELUTION SLR™ (Sustained Limus Release) drug eluting balloon (DEB)

This study will capture data from the use of the SELUTION SLR according to its approved labelling.

Trial Locations (27)

Unknown

Hospital Italiano La Plata, La Plata

Klinikum Hochsauerland, Arnsberg

Universitätsklinikum Freiburg, Bad Krozingen

Krankenhaus Buchholz, Buchholz

Universitätsklinikum Essen, Essen

DIAKO Krankenhaus, Flensburg

Medizinisches Versorgungszentrum, Hamburg

Universitätsklinikum Heidelberg, Heidelberg

SRH Klinikum Karlsbad - Langensteinbach, Langensteinbach

LMU Klinikum Campus Großhadern, München

Universitätsklinikum Tübingen, Tübingen

Grn Klinik Weinheim, Weinheim

Universitätsklinikum Würzburg, Würzburg

Athens Medical Center, Athens

Attikon University Hospital, Athens

General University Hospital of Patras, Pátrai

Elisabeth - TweeSteden Ziekenhuis, Tilburg

National University Hospital Singapore (NUHS), Singapore

Trnava University Hospital, Trnava

Kantonsspital Aarau, Aarau

Hôpitaux Universitaires de Genève (HUG), Geneva

Luzerner Kantonsspital, Lucerne

Frimley Park Hospital, Frimley

University Hospitals of Leicester NHS Trust, Leicester

Barts Health NHS Trust (ROYAL HOSPITAL LONDON), London

Guy's & St Thomas Hospital, London

East Surrey Hospital, Redhill

All Listed Sponsors
lead

M.A. Med Alliance S.A.

INDUSTRY